Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan
· Delayed Price · Currency is TWD 29.35
+0.05 (0.17%)
Apr 29, 2026, 1:30 PM CST
TPEX:4111 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,756 | 1,762 | 1,584 | 1,519 | 1,544 | 1,316 | Upgrade
|
| Market Cap Growth | 3.07% | 11.23% | 4.32% | -1.66% | 17.32% | -3.55% | Upgrade
|
| Enterprise Value | 1,336 | 1,366 | 1,313 | 1,268 | 1,425 | 1,261 | Upgrade
|
| Last Close Price | 29.35 | 29.45 | 25.69 | 23.73 | 23.07 | 18.87 | Upgrade
|
| PE Ratio | 10.79 | 10.73 | 14.32 | 22.11 | 10.03 | 16.30 | Upgrade
|
| PS Ratio | 1.28 | 1.28 | 1.36 | 1.43 | 1.35 | 1.29 | Upgrade
|
| PB Ratio | 1.27 | 1.28 | 1.24 | 1.25 | 1.26 | 1.20 | Upgrade
|
| P/TBV Ratio | 1.27 | 1.28 | 1.24 | 1.25 | 1.26 | 1.20 | Upgrade
|
| P/FCF Ratio | 9.72 | 9.75 | 12.28 | - | 14.10 | - | Upgrade
|
| P/OCF Ratio | 6.39 | 6.42 | 7.43 | 20.38 | 7.19 | 9.45 | Upgrade
|
| EV/Sales Ratio | 0.97 | 0.99 | 1.13 | 1.20 | 1.25 | 1.23 | Upgrade
|
| EV/EBITDA Ratio | 4.88 | 4.99 | 7.95 | 10.29 | 6.50 | 6.61 | Upgrade
|
| EV/EBIT Ratio | 6.70 | 6.85 | 13.27 | 20.71 | 9.26 | 10.60 | Upgrade
|
| EV/FCF Ratio | 7.39 | 7.56 | 10.18 | - | 13.01 | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.10 | 0.11 | 0.13 | Upgrade
|
| Debt / EBITDA Ratio | 0.09 | 0.09 | 0.16 | 1.00 | 0.57 | 0.73 | Upgrade
|
| Debt / FCF Ratio | 0.13 | 0.13 | 0.21 | - | 1.17 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.30 | -0.30 | -0.24 | -0.21 | -0.27 | -0.10 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.53 | -1.53 | -1.87 | -2.10 | -1.50 | -0.57 | Upgrade
|
| Net Debt / FCF Ratio | -2.32 | -2.32 | -2.40 | 9.57 | -2.99 | 0.86 | Upgrade
|
| Asset Turnover | 0.75 | 0.75 | 0.66 | 0.60 | 0.66 | 0.65 | Upgrade
|
| Inventory Turnover | 8.32 | 8.32 | 8.26 | 7.63 | 7.61 | 7.58 | Upgrade
|
| Quick Ratio | 1.74 | 1.74 | 1.83 | 1.57 | 1.54 | 1.20 | Upgrade
|
| Current Ratio | 2.01 | 2.01 | 2.11 | 1.78 | 1.78 | 1.46 | Upgrade
|
| Return on Equity (ROE) | 12.37% | 12.37% | 8.87% | 5.63% | 15.44% | 9.90% | Upgrade
|
| Return on Assets (ROA) | 6.76% | 6.76% | 3.52% | 2.15% | 5.56% | 4.73% | Upgrade
|
| Return on Invested Capital (ROIC) | 16.66% | 16.44% | 8.25% | 5.19% | 16.31% | 11.15% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.50% | 13.50% | 7.20% | 4.70% | 11.70% | 9.80% | Upgrade
|
| Earnings Yield | 9.35% | 9.32% | 6.98% | 4.52% | 9.97% | 6.13% | Upgrade
|
| FCF Yield | 10.29% | 10.26% | 8.14% | -1.78% | 7.09% | -9.54% | Upgrade
|
| Dividend Yield | 3.25% | - | 3.71% | 4.01% | 4.95% | 5.05% | Upgrade
|
| Payout Ratio | 36.76% | 34.69% | 51.51% | 99.57% | 37.00% | 70.57% | Upgrade
|
| Buyback Yield / Dilution | -0.40% | -0.40% | -0.12% | 0.16% | -0.06% | -0.10% | Upgrade
|
| Total Shareholder Return | 2.84% | -0.40% | 3.59% | 4.17% | 4.89% | 4.95% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.